Loading company…
Riskpilot
← Back to search
Sign in
Get full access
FOURTH WAVE THERAPEUTICS AS
AS
Active
Org 922754624
Eilert Sundts Gate 83, 3725 Skien
Programmeringstjenester · NACE 62010
Est. 2019
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2022
NOK 96K
-86% vs 2021
EBITDA margin
-328.3%
+51% vs 2021
Equity ratio
89.3%
Financial strength
Net profit 2022
NOK -367K
+48% vs 2021
EBITDA — year on year
NOK millions
0M
-0M
-1M
-1M
-1M
0M
2019
0M
0%
2020
-1M
-100%
2021
0M
+100%
2022
Key figures
Annual report 2022
Revenue
NOK 96K
-86%
EBITDA
NOK -316K
+51%
Net profit
NOK -367K
+48%
Total assets
NOK 136K
-78%
Equity
NOK 121K
+199%
Employees
0
—
Company information
Legal name
FOURTH WAVE THERAPEUTICS AS
Org number
922754624
Legal form
Aksjeselskap
NACE code
62010 · Programmeringstjenester
Founded
13. juni 2019
Share capital
NOK 3 000 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2022-12-31
Financial year
January – December
Signatory rights
Daglig leder alene.
Company purpose
Utvikling og salg av dataprogram for behandling av depresjoner.
Contact
Address
Eilert Sundts Gate 83, 3725 Skien
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Programmeringstjenester
Companies in Skien
All Norway companies
Revenue
NOK millions
0M
0M
1M
1M
1M
0M
2019
0M
2020
1M
2021
0M
2022
EBITDA
NOK millions
0M
0M
1M
1M
1M
0M
2019
0M
2020
-1M
2021
0M
2022
Income statement
NOK thousands
Item
2019
2020
2021
2022
Revenue
160
87
665
96
Staff expenses
−0
−0
−626
−95
EBITDA
−26
−30
−646
−316
Depreciation & amort.
−17
−67
−67
−50
EBIT
−43
−97
−712
−366
Net financials
−1
0
0
−1
Profit before tax
−44
−97
−712
−367
Tax
−0
−0
−0
−0
Net profit
−44
−97
−712
−367
Balance sheet
NOK thousands
Item
2019
2020
2021
2022
Total assets
331
137
631
136
Equity
−18
−115
−123
121
Long-term debt
0
250
250
0
Short-term debt
349
3
503
15
Total debt
349
253
753
15
Financial ratios
5-year trend
EBITDA margin
-328.3%
This company
15.8%
Market median
-2178% vs market
2019
2022
Equity ratio
89.3%
This company
38.2%
Market median
+134% vs market
2019
2022
Return on equity
-302.5%
This company
18.4%
Market median
-1744% vs market
2019
2022
Net profit margin
-380.9%
This company
8.1%
Market median
-4802% vs market
2019
2022
Asset turnover
0.71×
This company
1.12×
Market median
-37% vs market
2019
2022
Debt / equity
0.12×
This company
0.62×
Market median
+81% vs market
2019
2022
Annual reports & filings
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
Annual report 2019
Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (3)
TT
Torbjørn Tvedten
Chairman
2021
AL
Axel Lødemel Holene
Board of Directors
2021
ML
Morten Lystrup
Board of Directors
2021
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Gult Kort For Holding As
Company
80%
80%
2022
Unknown
Individual
20%
20%
2022
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
Gult Kort For Holding As
FOURTH WAVE THERAPEUTICS AS
(this company)
Board network connections
Board members of FOURTH WAVE THERAPEUTICS AS also hold positions in
0
other companies.
Person
Role here
Other companies
Torbjørn Tvedten
Chairman
0 companies
Axel Lødemel Holene
Board of Directors
0 companies
Morten Lystrup
Board of Directors
0 companies